Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones

Pancreas

Volumn 39, Issue 8, 2010, Pages 1167-1172

  Jörns, Anne ^a   Sennholz, Christoph ^a   Naujok, Ortwin ^a   Lenzen, Sigurd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

beta cell cycle; beta cell mass; glucocorticoids; neogenesis; pancreas transplantation; thyroid hormones

Indexed keywords

HYDROCORTISONE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL VOLUME; CONTROLLED STUDY; DRUG MECHANISM; NONHUMAN; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BROMODEOXYURIDINE; CELL COUNT; CELL PROLIFERATION; GLUCOCORTICOIDS; HOMEODOMAIN PROTEINS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INSULIN-SECRETING CELLS; PANCREATIC DUCTS; RATS; RATS, INBRED LEW; THYROID HORMONES; THYROXINE; TRANS-ACTIVATORS;

EID: 78049238101     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181dfce4f     Document Type: Article

References (27)

1. Lenzen S, Bailey CJ. Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr Rev. 1984;5:411-434.
2. Lenzen S. The effect of hydrocortisone treatment and adrenalectomy on insulin and glucagon secretion from the perfused rat pancreas. Endokrinologie. 1976;68:189-197.
3. Breant B, Gesina E, Blondeau B. Nutrition, glucocorticoids and pancreas development. Horm Res. 2006;65(suppl 3):98-104.
4. Lenzen S, Joost HG, Hasselblatt A. Thyroid function and insulin secretion from the perfused pancreas in the rat. Endocrinology. 1976;99:125-129.
5. Lenzen S, Klöppel G. Insulin secretion and the morphological and metabolic characteristics of pancreatic islets of hyperthyroid ob/ob mice. Endocrinology. 1978;103:1546-1555. (Pubitemid 9051841)
6. Jörns A, Tiedge M, Lenzen S. Thyroxine induces pancreatic beta cell apoptosis in rats. Diabetologia. 2002;45:851-855.
7. Bonner-Weir S, Sharma A. Are there pancreatic progenitor cells from which new islets form after birth? Nat Clin Pract Endocrinol Metab. 2006;2:240-241.
8. Juhl K, Bonner-Weir S, Sharma A. Regenerating pancreatic beta-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis. Curr Opin in Organ Transplant. 2010;15: 79-85.
9. Peters K, Panienka R, Li J, et al. Expression of stem cell markers and transcription factors during the remodeling of the rat pancreas after duct ligation. Virchows Arch. 2005;446:56-63.
10. Dieterle CD, Arbogast H, Illner WD, et al. Metabolic follow-up after long-term pancreas graft survival. Eur J Endocrinol. 2007;156: 603-610.
11. Pavlakis M, Khwaja K. Transplantation for type 1 diabetes: whole organ pancreas and islet cells. Curr Diab Rep. 2006;6:473-478.
12. Pavlakis M, Khwaja K. Pancreas and islet cell transplantation in diabetes. Curr Opin Endocrinol Diabetes Obes. 2007;14:146-150.
13. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
14. Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation. Methods Mol Biol. 2006;333:47-104.
15. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355: 1318-1330.
16. Truong W, Lakey JR, Ryan EA, et al. Clinical islet transplantation at the University of AlbertaVthe Edmonton experience. Clin Transpl. 2005;19:153-172.
17. Lenzen S. Dose-response studies on the inhibitory effect of thyroid hormones on insulin secretion in the rat. Metabolism. 1978;27: 81-88.
18. Jörns A, Günther A, Hedrich HJ, et al. Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes. 2005;54:2041-2052.
19. Jenny M, Uhl C, Roche C, et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 2002;21:6338-6347.
20. Naujok O, Francini F, Jörns A, et al. An efficient experimental strategy for mouse embryonic stem cell differentiation and separation of a cytokeratin-19-positive population of insulin-producing cells. Cell Prolif. 2008;41:607-624.
21. Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development. 2000;127:3533-3542.
22. Choi SB, Jang JS, Hong SM, et al. Exercise and dexamethasone oppositely modulate beta-cell function and survival via independent pathways in 90% pancreatectomized rats. J Endocrinol. 2006;190: 471-482.
23. Jörns A, Rath KJ, Bock O, et al. Beta cell death in hyperglycaemic Psammomys obesus is not cytokine-mediated. Diabetologia. 2006;49:2704-2712.
24. Uno S, Imagawa A, Okita K, et al. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia. 2007;50:596-601.
25. Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 2007;56:2356-2370.
26. Weksler-Zangen S, Raz I, Lenzen S, et al. Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic rat. Diabetes. 2008;57:279-287.
27. Schmied BM, Müller SA, Mehrabi A, et al. Immunosuppressive standards in simultaneous kidney-pancreas transplantation. Clin Transplant. 2006;20(suppl 17):44-50.